Home | News | Donate | Directions | Careers

State-Of-The-Art Tumor Treatment
Offers New Hope to Patients

The CyberKnife team consists of a multidisciplinary
group of physicians with a wide range of expertise.
Pictured (left to right): Lawrence Chin, M.D., F.A.C.S.,
chief of neurosurgery at Boston Medical Center and
Michael Ebright, M.D., surgeon in Boston Medical
Center's Center for Thoracic Oncology.

The words “cancer,” “tumor” or “inoperable” always come as a shock. Some patients with difficult to treat tumors endure complex surgery and multiple rounds of chemotherapy and radiation. Others learn their tumors are untreatable. Now, for many patients, there is another option in Boston: CyberKnife®.

Boston Medical Center (BMC) is the only hospital in Boston that offers the most advanced CyberKnife Robotic Radiosurgery System. With CyberKnife, BMC can now treat a variety of cancerous and non-cancerous tumors once considered inoperable or difficult to treat. This non-invasive, cutting edge technology delivers focused beams of radiation with pinpoint accuracy – treating tumors while limiting radiation exposure to healthy tissue. CyberKnife has been shown to be effective at treating numerous cancers including those in the brain and spine, lung, liver and pancreas.

When his doctors at BMC discovered that Donald Gurney of East Freetown had an inoperable, cancerous tumor in his liver – it was so close to a main vein that surgery to remove the tumor was not possible – he was successfully treated with the CyberKnife.

“The machine amazed me as it moved around and concentrated on my liver from multiple angles,” says Donald. “I couldn’t feel a thing and nothing touched me. All I had to do was lie still.” Donald also explains how after each treatment he was able to immediately resume his regular routine. “They treated me so well at BMC and my treatments only took a few days. I’d tell anyone who needs this type of treatment to have it at Boston Medical Center!”

Four months later, Donald’s tumor has had an excellent response to the CyberKnife treatment. “I’m very thankful to Boston Medical Center,” says Donald. “I’m hoping to beat the cancer so that I can celebrate 60 wonderful years married to the love of my life.”

Donald Gurney of East Freetown and
his wife, Miriam.

For patients with tumors in the lung or the abdomen, the CyberKnife at BMC includes a tumor tracking system that maintains high accuracy even when breathing motion causes the tumor to move during treatment. If the tumor does move, the CyberKnife moves to follow it, keeping the beam always on target. The CyberKnife is the only machine that has this capability.

CyberKnife is also effective for treatment of benign disorders such as meningiomas, acoustic neuromas, pituitary adenomas and trigeminal neuralgia. “Since we are able to deliver a very high dose of radiation with such accuracy, the patient’s surrounding healthy tissue is subjected to minimal harm,” says Lisa Kachnic, M.D., chief of radiation oncology at BMC. “There is no surgery, no drugs, no pain, and only minimal fatigue, and patients can go back to normal activities directly after treatment.” Depending on the size and location of the tumor, added Kachnic, patients receive between one and five treatments with CyberKnife.

“This advanced procedure is available to anyone who needs it,” says Lawrence Chin, M.D., chief of neurosurgery at BMC and one of the 10 physicians trained to use CyberKnife. “CyberKnife offers new hope to patients who may have given up on other treatments.”

To learn more about CyberKnife at Boston Medical Center, visit http://bmc.org/cyber-knife or call 800.841.4325 (toll-free).

CyberKnife is a registered trademark of Accuray Incorporated and is used with permission.